Gary Tin - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Gary Tin

Showing results (31-40 of 34) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 34 results.

Cancer Cell|January 16, 2019

The ERBB-STAT3 Axis Drives Tasmanian Devil Facial Tumor DiseaseLindsay Kosack, Bettina Wingelhofer, Alexandra Popa, et al.

Science (New York, N.Y.)|April 25, 2024

Large-scale chemoproteomics expedites ligand discovery and predicts ligand behavior in cellsFabian Offensperger, Gary Tin, Miquel Duran-Frigola, et al.

Molecular Cancer|October 15, 2025

Thyroid hormone receptor beta signaling is a targetable driver of prostate cancer growthAleksandra Fesiuk, Daniel Pölöske, Elvin D de Araujo, et al.

EMBO Molecular Medicine|November 7, 2022

Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T-cell lymphomaHelena Sorger, Saptaswa Dey, Pablo Augusto Vieyra-Garcia, et al.

Pageof 4

Search research articles

Showing results (31-40 of 34) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 34 results.

Cancer Cell|January 16, 2019

The ERBB-STAT3 Axis Drives Tasmanian Devil Facial Tumor DiseaseLindsay Kosack, Bettina Wingelhofer, Alexandra Popa, et al.

Science (New York, N.Y.)|April 25, 2024

Large-scale chemoproteomics expedites ligand discovery and predicts ligand behavior in cellsFabian Offensperger, Gary Tin, Miquel Duran-Frigola, et al.

Molecular Cancer|October 15, 2025

Thyroid hormone receptor beta signaling is a targetable driver of prostate cancer growthAleksandra Fesiuk, Daniel Pölöske, Elvin D de Araujo, et al.

EMBO Molecular Medicine|November 7, 2022

Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T-cell lymphomaHelena Sorger, Saptaswa Dey, Pablo Augusto Vieyra-Garcia, et al.

Pageof 4